Skip to main content
Top
Published in: Diabetologia 1/2005

01-01-2005 | Article

C-peptide stimulates ERK1/2 and JNK MAP kinases via activation of protein kinase C in human renal tubular cells

Authors: Z. Zhong, A. Davidescu, I. Ehrén, K. Ekberg, H. Jörnvall, J. Wahren, A. V. Chibalin

Published in: Diabetologia | Issue 1/2005

Login to get access

Abstract

Aims/hypothesis

Accumulating evidence indicates that replacement of C-peptide in type 1 diabetes ameliorates nerve and kidney dysfunction, but the molecular mechanisms involved are incompletely understood. C-peptide shows specific binding to a G-protein-coupled membrane binding site, resulting in Ca2+ influx, activation of mitogen-activated protein kinase signalling pathways, and stimulation of Na+, K+-ATPase and endothelial nitric oxide synthase. This study examines the intracellular signalling pathways activated by C-peptide in human renal tubular cells.

Methods

Human renal tubular cells were cultured from the outer cortex of renal tissue obtained from patients undergoing elective nephrectomy. Extracellular-signal-regulated kinase 1/2 (ERK1/2), c-Jun N-terminal kinase (JNK) and Akt/protein kinase B (PKB) activation was determined using phospho-specific antibodies. Protein kinase C (PKC) and RhoA activation was determined by measuring their translocation to the cell membrane fraction using isoform-specific antibodies.

Results

Human C-peptide increases phosphorylation of ERK1/2 and Akt/PKB in a concentration- and time-dependent manner in renal tubular cells. The C-terminal pentapeptide of C-peptide is equipotent with the full-length C-peptide, whereas scrambled C-peptide has no effect. C-peptide stimulation also results in phosphorylation of JNK, but not of p38 mitogen-activated protein kinase. MEK1/2 inhibitor PD98059 blocks the C-peptide effect on ERK1/2 phosphorylation. C-peptide causes specific translocation of PKC isoforms δ and ɛ to the membrane fraction in tubular cells. All stimulatory effects of C-peptide were abolished by pertussis toxin. The isoform-specific PKC-δ inhibitor rottlerin and the broad-spectrum PKC inhibitor GF109203X both abolish the C-peptide effect on ERK1/2 phosphorylation. C-peptide stimulation also causes translocation of the small GTPase RhoA from the cytosol to the cell membrane. Inhibition of phospholipase C abolished the stimulatory effect of C-peptide on phosphorylation of ERK1/2, JNK and PKC-δ.

Conclusions/interpretation

C-peptide signal transduction in human renal tubular cells involves the activation of phospholipase C and PKC-δ and PKC-ɛ, as well as RhoA, followed by phosphorylation of ERK1/2 and JNK, and a parallel activation of Akt.
Literature
1.
go back to reference Rigler R, Pramanik A, Jonasson P et al (1999) Specific binding of proinsulin C-peptide to human cell membranes. Proc Natl Acad Sci U S A 96:13318–13323CrossRef Rigler R, Pramanik A, Jonasson P et al (1999) Specific binding of proinsulin C-peptide to human cell membranes. Proc Natl Acad Sci U S A 96:13318–13323CrossRef
2.
go back to reference Shafqat J, Juntti-Berggren L, Zhong Z et al (2002) Proinsulin C-peptide and its analogues induce intracellular Ca2+ increases in human renal tubular cells. Cell Mol Life Sci 59:1185–1189CrossRef Shafqat J, Juntti-Berggren L, Zhong Z et al (2002) Proinsulin C-peptide and its analogues induce intracellular Ca2+ increases in human renal tubular cells. Cell Mol Life Sci 59:1185–1189CrossRef
3.
go back to reference Kitamura T, Kimura K, Okamoto S et al (2001) Proinsulin C-peptide rapidly stimulates mitogen-activated protein kinases in Swiss 3T3 fibroblasts: requirement of protein kinase C, phosphoinositide 3-kinase and pertussis toxin-sensitive G-protein. Biochem J 355:123–129CrossRef Kitamura T, Kimura K, Okamoto S et al (2001) Proinsulin C-peptide rapidly stimulates mitogen-activated protein kinases in Swiss 3T3 fibroblasts: requirement of protein kinase C, phosphoinositide 3-kinase and pertussis toxin-sensitive G-protein. Biochem J 355:123–129CrossRef
4.
go back to reference Grunberger G, Qiang X, Li Z et al (2001) Molecular basis for the insulinomimetic effects of C-peptide. Diabetologia 44:1247–1257CrossRef Grunberger G, Qiang X, Li Z et al (2001) Molecular basis for the insulinomimetic effects of C-peptide. Diabetologia 44:1247–1257CrossRef
5.
go back to reference Wallerath T, Kunt T, Forst T et al (2003) Stimulation of endothelial nitric oxide synthase by proinsulin C-peptide. Nitric Oxide 9:95–102CrossRef Wallerath T, Kunt T, Forst T et al (2003) Stimulation of endothelial nitric oxide synthase by proinsulin C-peptide. Nitric Oxide 9:95–102CrossRef
6.
go back to reference Ohtomo Y, Aperia A, Sahlgren B, Johansson B-L, Wahren J (1996) C-peptide stimulates rat renal tubular Na+, K+-ATPase activity in synergism with neuropeptide Y. Diabetologia 39:199–205CrossRef Ohtomo Y, Aperia A, Sahlgren B, Johansson B-L, Wahren J (1996) C-peptide stimulates rat renal tubular Na+, K+-ATPase activity in synergism with neuropeptide Y. Diabetologia 39:199–205CrossRef
7.
go back to reference Tsimaratos M, Roger F, Chabardès D et al (2003) C-Peptide stimulates Na, K-ATPase activity via PKC alpha in rat medullary thick ascending limb. Diabetologia 46:124–131 Tsimaratos M, Roger F, Chabardès D et al (2003) C-Peptide stimulates Na, K-ATPase activity via PKC alpha in rat medullary thick ascending limb. Diabetologia 46:124–131
8.
go back to reference Kitamura T, Kimura K, Makondo K et al (2003) Proinsulin C-peptide increases nitric oxide production through mitogen-activated protein kinase-dependent transcriptional enhancement of endothelial nitric oxide synthase in rat aortic endothelial cells. Diabetologia 46:1698–1705CrossRef Kitamura T, Kimura K, Makondo K et al (2003) Proinsulin C-peptide increases nitric oxide production through mitogen-activated protein kinase-dependent transcriptional enhancement of endothelial nitric oxide synthase in rat aortic endothelial cells. Diabetologia 46:1698–1705CrossRef
9.
go back to reference Zochodne DW, Verge VM, Cheng C et al (2000) Nitric oxide synthase activity and expression in experimental diabetic neuropathy. J Neuropathol Exp Neurol 59:798–807 Zochodne DW, Verge VM, Cheng C et al (2000) Nitric oxide synthase activity and expression in experimental diabetic neuropathy. J Neuropathol Exp Neurol 59:798–807
10.
go back to reference Greene DA, Yagihashi S, Lattimer SA, Sima AA (1984) Nerve Na+–K+-ATPase, conduction, and myo-inositol in the insulin-deficient BB rat. Am J Physiol 247:E534–E539 Greene DA, Yagihashi S, Lattimer SA, Sima AA (1984) Nerve Na+–K+-ATPase, conduction, and myo-inositol in the insulin-deficient BB rat. Am J Physiol 247:E534–E539
11.
go back to reference Kjeldsen K, Braendgaard H, Sidenius P, Larsen J, Norgaard A (1987) Diabetes decreases Na+–K+ pump concentration in skeletal muscle, heart ventricular muscle, and peripheral nerves of rat. Diabetes 36:842–848 Kjeldsen K, Braendgaard H, Sidenius P, Larsen J, Norgaard A (1987) Diabetes decreases Na+–K+ pump concentration in skeletal muscle, heart ventricular muscle, and peripheral nerves of rat. Diabetes 36:842–848
12.
go back to reference Wald H, Scherzer P, Rasch R, Popovtzer M (1993) Renal tubular Na+–K+-ATPase in diabetes mellitus: relationship to metabolic abnormality. Am J Physiol 265:F96–F101 Wald H, Scherzer P, Rasch R, Popovtzer M (1993) Renal tubular Na+–K+-ATPase in diabetes mellitus: relationship to metabolic abnormality. Am J Physiol 265:F96–F101
13.
go back to reference Johansson B-L, Borg K, Fernqvist-Forbes E, Kernell A, Odergren T, Wahren J (2000) Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with type I diabetes. Diabet Med 17:181–189CrossRef Johansson B-L, Borg K, Fernqvist-Forbes E, Kernell A, Odergren T, Wahren J (2000) Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with type I diabetes. Diabet Med 17:181–189CrossRef
14.
go back to reference Ekberg K, Brismar T, Johansson B-L, Jonsson B, Lindström P, Wahren J (2003) Amelioration of sensory nerve dysfunction by C-peptide in patients with type 1 diabetes. Diabetes 52:536–541 Ekberg K, Brismar T, Johansson B-L, Jonsson B, Lindström P, Wahren J (2003) Amelioration of sensory nerve dysfunction by C-peptide in patients with type 1 diabetes. Diabetes 52:536–541
15.
go back to reference Sima AA, Zhang W, Sugimoto K et al (2001) C-Peptide prevents and improves chronic type 1 diabetic neuropathy in the BB/Wor rat. Diabetologia 44:889–897CrossRefPubMed Sima AA, Zhang W, Sugimoto K et al (2001) C-Peptide prevents and improves chronic type 1 diabetic neuropathy in the BB/Wor rat. Diabetologia 44:889–897CrossRefPubMed
16.
go back to reference Pierson C, Zhang W, Sima A (2003) Proinuslin C-peptide replacement in type 1 diabetic BB/Wor-rats prevents deficits in nerve fiber regeneration. J Neuropathol Exp Neurol 62:765–779 Pierson C, Zhang W, Sima A (2003) Proinuslin C-peptide replacement in type 1 diabetic BB/Wor-rats prevents deficits in nerve fiber regeneration. J Neuropathol Exp Neurol 62:765–779
17.
go back to reference Li Z, Zhang W, Sima A (2002) C-Peptide prevents hippocampal apoptosis in type 1 diabetes. Int J Exp Diabetes Res 3:241–245CrossRef Li Z, Zhang W, Sima A (2002) C-Peptide prevents hippocampal apoptosis in type 1 diabetes. Int J Exp Diabetes Res 3:241–245CrossRef
18.
go back to reference Li Z, Zhang W, Sima A (2003) C-Peptide enhances insulin-mediated cell growth and protection against high glucose-induced apoptosis in SH-SY5Y cells. Diabetes Metab Res Rev 19:375–385CrossRef Li Z, Zhang W, Sima A (2003) C-Peptide enhances insulin-mediated cell growth and protection against high glucose-induced apoptosis in SH-SY5Y cells. Diabetes Metab Res Rev 19:375–385CrossRef
19.
go back to reference Samnegård B, Jacobson S, Jaremko G, Johansson B-L, Sjöquist M (2001) Effects of C-peptide on glomerular and renal size and renal function in diabetic rats. Kidney Int 60:1258–1265CrossRef Samnegård B, Jacobson S, Jaremko G, Johansson B-L, Sjöquist M (2001) Effects of C-peptide on glomerular and renal size and renal function in diabetic rats. Kidney Int 60:1258–1265CrossRef
20.
go back to reference Johansson B-L, Kernell A, Sjöberg S, Wahren J (1993) Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1. J Clin Endocrinol Metab 77:976–981CrossRef Johansson B-L, Kernell A, Sjöberg S, Wahren J (1993) Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1. J Clin Endocrinol Metab 77:976–981CrossRef
21.
go back to reference Johansson B-L, Pernow J, Wahren J (2003) C-Peptide increases forearm blood flow in patients with type 1 diabetes via a nitric oxide dependent mechanism. Am J Physiol Endocrinol Metab 285:E864–E870 Johansson B-L, Pernow J, Wahren J (2003) C-Peptide increases forearm blood flow in patients with type 1 diabetes via a nitric oxide dependent mechanism. Am J Physiol Endocrinol Metab 285:E864–E870
22.
go back to reference Hansen A, Johansson B-L, Wahren J, Bibra von H (2002) C-Peptide exerts beneficial effects on myocardial blood flow and function in patients with type 1 diabetes. Diabetes 51:3077–3082 Hansen A, Johansson B-L, Wahren J, Bibra von H (2002) C-Peptide exerts beneficial effects on myocardial blood flow and function in patients with type 1 diabetes. Diabetes 51:3077–3082
23.
go back to reference Johansson B-L, Sundell J, Ekberg K et al (2004) C-Peptide improves adenosine-induced myocardial vasodilation in type 1 diabetes patients. Am J Physiol Endocrinol Metab 286:E14–E19CrossRef Johansson B-L, Sundell J, Ekberg K et al (2004) C-Peptide improves adenosine-induced myocardial vasodilation in type 1 diabetes patients. Am J Physiol Endocrinol Metab 286:E14–E19CrossRef
24.
go back to reference Pearson G, Robinson F, Beers Gibson T et al (2001) Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22:153–158CrossRefPubMed Pearson G, Robinson F, Beers Gibson T et al (2001) Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22:153–158CrossRefPubMed
25.
go back to reference Toker A (1998) Signaling through protein kinase C. Front Biosci 3:D1134–D1147 Toker A (1998) Signaling through protein kinase C. Front Biosci 3:D1134–D1147
26.
go back to reference Al-Rasheed N, Meakin F, Royal E et al (2004) Potent activation of multiple signalling pathways by C-peptide in opossum kidney proximal tubular cells. Diabetologia 47:987–997CrossRef Al-Rasheed N, Meakin F, Royal E et al (2004) Potent activation of multiple signalling pathways by C-peptide in opossum kidney proximal tubular cells. Diabetologia 47:987–997CrossRef
27.
go back to reference Kitamura T, Kimura K, Jung B et al (2002) Proinsulin C-peptide activates cAMP response element-binding proteins through the p38 mitogen-activated protein kinase pathway in mouse lung capillary endothelial cells. Biochem J 366:737–744 Kitamura T, Kimura K, Jung B et al (2002) Proinsulin C-peptide activates cAMP response element-binding proteins through the p38 mitogen-activated protein kinase pathway in mouse lung capillary endothelial cells. Biochem J 366:737–744
28.
go back to reference Söderhäll M, Bergerheim U, Jacobson S et al (1997) Molecular evidence for pap-G specific adhesion of Escherichia coli to human renal cells. J Urol 157:346–350CrossRef Söderhäll M, Bergerheim U, Jacobson S et al (1997) Molecular evidence for pap-G specific adhesion of Escherichia coli to human renal cells. J Urol 157:346–350CrossRef
29.
go back to reference Lopez-Ilasaca M (1998) Signaling from G-protein-coupled receptors to mitogen-activated protein (MAP)-kinase cascades. Biochem Pharmacol 3:269–277CrossRef Lopez-Ilasaca M (1998) Signaling from G-protein-coupled receptors to mitogen-activated protein (MAP)-kinase cascades. Biochem Pharmacol 3:269–277CrossRef
30.
go back to reference Kranenburg O, Moolenaar W (2001) Ras-MAP kinase signaling by lysophosphatidic acid and other G protein-coupled receptor agonists. Oncogene 13:1540–1546CrossRef Kranenburg O, Moolenaar W (2001) Ras-MAP kinase signaling by lysophosphatidic acid and other G protein-coupled receptor agonists. Oncogene 13:1540–1546CrossRef
31.
go back to reference Ohtomo Y, Bergman T, Johansson B-L, Jörnvall H, Wahren J (1998) Differential effects of proinsulin C-peptide fragments on Na+, K+-ATPase activity of renal tubule segments. Diabetologia 41:287–291CrossRef Ohtomo Y, Bergman T, Johansson B-L, Jörnvall H, Wahren J (1998) Differential effects of proinsulin C-peptide fragments on Na+, K+-ATPase activity of renal tubule segments. Diabetologia 41:287–291CrossRef
32.
go back to reference Ido Y, Vindigni A, Chang K et al (1997) Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science 277:563–566CrossRef Ido Y, Vindigni A, Chang K et al (1997) Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science 277:563–566CrossRef
33.
go back to reference Stoyanov B, Volinia S, Hanck T et al (1995) Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase. Science 269:690–693PubMed Stoyanov B, Volinia S, Hanck T et al (1995) Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase. Science 269:690–693PubMed
34.
go back to reference Toker A, Cantley L (1997) Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 6634:673–676CrossRef Toker A, Cantley L (1997) Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 6634:673–676CrossRef
35.
go back to reference Bernstein H, Keilhoff G, Reiser M, Freese S, Wetzker R (1998) Tissue distribution and subcellular localization of a G-protein activated phosphoinositide 3-kinase. An immunohistochemical study. Cell Mol Biol (Noisy-le-grand) 44:973–983 Bernstein H, Keilhoff G, Reiser M, Freese S, Wetzker R (1998) Tissue distribution and subcellular localization of a G-protein activated phosphoinositide 3-kinase. An immunohistochemical study. Cell Mol Biol (Noisy-le-grand) 44:973–983
36.
go back to reference Li Z, Qiang X, Sima A, Grunberger G (2001) C-Peptide attenuates protein tyrosine phosphatase activity and enhances glycogen synthesis in L6 myoblasts. Biochem Biophys Res Commun 280:615–619CrossRef Li Z, Qiang X, Sima A, Grunberger G (2001) C-Peptide attenuates protein tyrosine phosphatase activity and enhances glycogen synthesis in L6 myoblasts. Biochem Biophys Res Commun 280:615–619CrossRef
37.
go back to reference Zierath J, Handberg A, Tally M, Wallberg-Henriksson H (1996) C-Peptide stimulates glucose transport in isolated human skeletal muscle independent of insulin receptor and tyrosine kinase activation. Diabetologia 39:306–313 Zierath J, Handberg A, Tally M, Wallberg-Henriksson H (1996) C-Peptide stimulates glucose transport in isolated human skeletal muscle independent of insulin receptor and tyrosine kinase activation. Diabetologia 39:306–313
38.
go back to reference Rhee S, Bae Y (1997) Regulation of phosphoinositide-specific phospholipase C isozymes. J Biol Chem 272:15045–15048CrossRef Rhee S, Bae Y (1997) Regulation of phosphoinositide-specific phospholipase C isozymes. J Biol Chem 272:15045–15048CrossRef
39.
go back to reference Newton A (1995) Protein kinase C: structure, function and regulation. J Biol Chem 270:28495–28498CrossRef Newton A (1995) Protein kinase C: structure, function and regulation. J Biol Chem 270:28495–28498CrossRef
40.
go back to reference Hofmann J (1997) The potential for isoenzyme-selective modulation of protein kinase C. FASEB J 11:649–669 Hofmann J (1997) The potential for isoenzyme-selective modulation of protein kinase C. FASEB J 11:649–669
41.
go back to reference Keef K, Hume J, Zhong J (2001) Regulation of cardiac and smooth muscle Ca(2+) channels (Ca(V)1.2a, b) by protein kinases. Am J Physiol Cell Physiol 281:C1743–C1756 Keef K, Hume J, Zhong J (2001) Regulation of cardiac and smooth muscle Ca(2+) channels (Ca(V)1.2a, b) by protein kinases. Am J Physiol Cell Physiol 281:C1743–C1756
42.
go back to reference Kamp T, Hell J (2000) Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C. Circ Res 87:1095–1102PubMed Kamp T, Hell J (2000) Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C. Circ Res 87:1095–1102PubMed
43.
go back to reference Hantash B, Thomas A, Reeves J (2000) Dual effect on protein kinase C on L-type calcium activity in L6 cells. Biophys J 78:203A Hantash B, Thomas A, Reeves J (2000) Dual effect on protein kinase C on L-type calcium activity in L6 cells. Biophys J 78:203A
44.
go back to reference Agrell N, Bachs O, Rocamora N, Villalonga P (2002) Modulation of the Ras/Raf/MEK/ERK pathway by Ca(2+), and calmodulin. Cell Signal 14:649–654CrossRef Agrell N, Bachs O, Rocamora N, Villalonga P (2002) Modulation of the Ras/Raf/MEK/ERK pathway by Ca(2+), and calmodulin. Cell Signal 14:649–654CrossRef
45.
go back to reference Gutkind J (2000) Regulation of mitogen-activated protein kinase signaling networks by G protein-coupled receptors. Sci Signal Transduct Knowl Environ 40:RE1 Gutkind J (2000) Regulation of mitogen-activated protein kinase signaling networks by G protein-coupled receptors. Sci Signal Transduct Knowl Environ 40:RE1
46.
go back to reference Lawlor M, Alessi D (2001) PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? J Cell Sci 114:2903–2910 Lawlor M, Alessi D (2001) PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? J Cell Sci 114:2903–2910
47.
go back to reference Lecuona E, Ridge K, Pesce L, Batlle D, Sznajder JI (2003) The GTP-binding protein RhoA mediates Na, K-ATPase exocytosis in alveolar epithelial cells. Mol Biol Cell 14:3888–3897CrossRef Lecuona E, Ridge K, Pesce L, Batlle D, Sznajder JI (2003) The GTP-binding protein RhoA mediates Na, K-ATPase exocytosis in alveolar epithelial cells. Mol Biol Cell 14:3888–3897CrossRef
Metadata
Title
C-peptide stimulates ERK1/2 and JNK MAP kinases via activation of protein kinase C in human renal tubular cells
Authors
Z. Zhong
A. Davidescu
I. Ehrén
K. Ekberg
H. Jörnvall
J. Wahren
A. V. Chibalin
Publication date
01-01-2005
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 1/2005
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-004-1602-5

Other articles of this Issue 1/2005

Diabetologia 1/2005 Go to the issue

list of referees

List of referees

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.